Published in Vaccine Weekly, August 30th, 2006
According to recent research from Italy, "The ability of viruses to selectively target, replicate within, and destroy tumor cells without deleterious effects in normal cells (oncolysis), makes the use of viruses as an attractive tool for cancer treatment. Pancreatic adenocarcinoma, being insensitive to traditional therapy and having a rather poor prognosis, represents a suitable target to evaluate viral oncolysis as a novel therapeutic approach."
"Herpes simplex virus (HSV) has been reported to produce an oncolytic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly